BASEL, SWITZERLAND: Lonza Group Ltd said that it is in final talks with KKR & Co, a private equity firm, regarding the potential acquisition of Capsugel.
Capsugel, a portfolio company of KKR, is a producer of capsule products and other drug delivery systems. It is headquartered in Morristown, US.
The company confirms that it has expressed a strong interest in this successful company as it would fit perfectly with Lonza’s Healthcare Continuum strategy and strengthen its position as leading supplier to a number of important healthcare markets.
A successful acquisition would be value adding and be within Lonza’s stated acquisition criteria, the company said.
Lonza highlights that there can be no certainty as to the outcome of the discussions or whether an acquisition will be completed. More detailed information will follow in case of any significant developments and does not intend to comment further.
Read More: Lonza confirms talks to acquire Capsugel
No comments:
Post a Comment